Zivo Bioscience Files 8-K Report
Ticker: ZIVOW · Form: 8-K · Filed: Jan 7, 2025 · CIK: 1101026
| Field | Detail |
|---|---|
| Company | Zivo Bioscience, Inc. (ZIVOW) |
| Form Type | 8-K |
| Filed Date | Jan 7, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure
TL;DR
ZIVO filed an 8-K on Jan 7, 2025 for an 'Other Event' - details TBD.
AI Summary
On January 7, 2025, Zivo Bioscience, Inc. filed an 8-K report detailing an "Other Event." The filing does not contain specific financial figures or significant business developments beyond the reporting of the event itself.
Why It Matters
This filing indicates a formal disclosure to the SEC, suggesting a material event has occurred that requires public notification.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for an 'Other Event' without immediate disclosed financial impact or significant operational changes.
Key Players & Entities
- Zivo Bioscience, Inc. (company) — Registrant
- January 7, 2025 (date) — Date of earliest event reported
FAQ
What specific event is Zivo Bioscience reporting under 'Other Events'?
The filing does not specify the exact nature of the 'Other Event' beyond its classification.
Does this 8-K filing include any financial updates or material business changes?
No, this 8-K filing, as presented, does not contain specific financial figures or details of material business changes.
When was this 8-K report filed?
The report was filed on January 7, 2025.
What is Zivo Bioscience's principal executive office address?
The principal executive offices are located at 21 East Long Lake Road, Suite 100, Bloomfield Hills, Michigan 48304.
What is Zivo Bioscience's state of incorporation?
Zivo Bioscience, Inc. is incorporated in Nevada.
Filing Stats: 388 words · 2 min read · ~1 pages · Grade level 11.4 · Accepted 2025-01-07 16:05:22
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share ZIVO OTCQB Warrants to
Filing Documents
- zivo_8k.htm (8-K) — 22KB
- 0001654954-25-000173.txt ( ) — 155KB
- zivo-20250107.xsd (EX-101.SCH) — 6KB
- zivo-20250107_lab.xml (EX-101.LAB) — 15KB
- zivo-20250107_cal.xml (EX-101.CAL) — 1KB
- zivo-20250107_pre.xml (EX-101.PRE) — 11KB
- zivo-20250107_def.xml (EX-101.DEF) — 4KB
- zivo_8k_htm.xml (XML) — 5KB
01. Other Events
Item 8.01. Other Events. Effective on January 6, 2025, the Company formally changed the listing of its principal executive office to 2125 Butterfield Drive, Suite 100, Troy, Michigan 48084. The Company's telephone number remains the same: +1 (248) 452-9866. 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ZIVO BIOSCIENCE, INC. By: /s/ Keith Marchiando Keith Marchiando Chief Financial Officer Date: January 7, 2025 3